Back to 
B. Metzler seel. Sohn & Co. AG
B. Metzler seel. Sohn & Co. AG
DYN
Showing 0 of 7 quarters
Position history for B. Metzler seel. Sohn & Co. AG's holdings in Dyne Therapeutics, Inc.
No. B. Metzler seel. Sohn exited its DYN (Dyne Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 19,962 shares worth $265,495. B. Metzler seel. Sohn first reported DYN in Q3 2022 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.